These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 221549

  • 21. Hepatocellular carcinoma and partial deficiency of alpha-1 antitrypsin (MZ).
    Rawlings W, Moss J, Cooper HS, Hamilton SR.
    Ann Intern Med; 1974 Dec; 81(6):771-3. PubMed ID: 4372920
    [No Abstract] [Full Text] [Related]

  • 22. Cytologic, ultrastructural and immunologic features of intracytoplasmic hyaline bodies in fine needle aspirates of hepatocellular carcinoma.
    MacDonald K, Bedard YC.
    Acta Cytol; 1990 Dec; 34(2):197-200. PubMed ID: 2157323
    [Abstract] [Full Text] [Related]

  • 23. Chronic 'cryptogenic' liver disease and malignant hepatoma in intermediate alpha 1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody.
    Carlson J, Eriksson S.
    Scand J Gastroenterol; 1985 Sep; 20(7):835-42. PubMed ID: 2996119
    [Abstract] [Full Text] [Related]

  • 24. Alpha-antitrypsin deposition in primary hepatic carcinomas.
    Palmer PE, Wolfe HJ.
    Arch Pathol Lab Med; 1976 May; 100(5):232-6. PubMed ID: 57764
    [Abstract] [Full Text] [Related]

  • 25. Hepatocytic PAS-positive diastase-resistance inclusions in the absence of alpha-1-antitrypsin deficiency--high prevalence in alcoholic cirrhosis.
    Pariente EA, Degott C, Martin JP, Feldmann G, Potet F, Benhamou JP.
    Am J Clin Pathol; 1981 Sep; 76(3):299-302. PubMed ID: 6169273
    [Abstract] [Full Text] [Related]

  • 26. Does the Z gene variant of alpha-1-antitrypsin predispose to hepatic carcinoma?
    Reintoft I, Hägerstrand IE.
    Hum Pathol; 1979 Jul; 10(4):419-24. PubMed ID: 223964
    [Abstract] [Full Text] [Related]

  • 27. [Heterozygous alpha-1-antitrypsin deficiency (PiMZ): risk factor in the development of primary liver carcinoma in non-cirrhotic liver?].
    Manekeller S, Sauerbruch T, Fischer HP, Propping P, Hirner A.
    Z Gastroenterol; 2010 Oct; 48(10):1211-4. PubMed ID: 20886426
    [Abstract] [Full Text] [Related]

  • 28. [Primary liver cell carcinoma as complication of alpha 1-antitrypsin deficiency in a 67 year old man].
    van den Hazel SJ, Meijer JW, van den Elshout FJ, de Vries RA.
    Ned Tijdschr Geneeskd; 2000 Nov 18; 144(47):2269-72. PubMed ID: 11109473
    [Abstract] [Full Text] [Related]

  • 29. [Immunofluorescence with anti-alpha-1-antitrypsin antibody in hepatocarcinoma].
    Millán Núñez-Cortes J, Calvo Manuel E, Elías Arcalís AM, Espinós Pérez D.
    Rev Clin Esp; 1981 Dec 15; 163(5):345-7. PubMed ID: 6281857
    [No Abstract] [Full Text] [Related]

  • 30. Alpha 1 antitrypsin liver disease differential diagnosis of PAS-positive, diastase-resistant globules in liver cells.
    Qizilbash A, Young-Pong O.
    Am J Clin Pathol; 1983 Jun 15; 79(6):697-702. PubMed ID: 6189389
    [Abstract] [Full Text] [Related]

  • 31. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
    Tiniakos D, Spandidos DA, Kakkanas A, Pintzas A, Pollice L, Tiniakos G.
    Anticancer Res; 1989 Jun 15; 9(3):715-21. PubMed ID: 2548435
    [Abstract] [Full Text] [Related]

  • 32. [Liver changes suggesting alpha-1-antitrypsin deficiency (a neglected disease)].
    Bartók I, Korányi G, Bartók K, Nádor K, Hegedüs C.
    Orv Hetil; 1989 Sep 03; 130(36):1911-6, 1919. PubMed ID: 2674844
    [Abstract] [Full Text] [Related]

  • 33. Hepatocellular carcinoma in a long-term survivor of acute lymphocytic leukemia.
    Fried M, Kalra J, Ilardi CF, Sawitsky A.
    Cancer; 1987 Nov 15; 60(10):2548-52. PubMed ID: 2444327
    [Abstract] [Full Text] [Related]

  • 34. Expression of Mallory bodies in hepatocellular carcinoma in man and its significance.
    Nakanuma Y, Ohta G.
    Cancer; 1986 Jan 01; 57(1):81-6. PubMed ID: 2416424
    [Abstract] [Full Text] [Related]

  • 35. Natural history of hepatocellular carcinoma as viewed by the pathologist.
    Callea F.
    Appl Pathol; 1988 Jan 01; 6(2):105-16. PubMed ID: 2839213
    [Abstract] [Full Text] [Related]

  • 36. Hepatocellular ubiquitin expression in alpha1-antitrypsin deficiency.
    Wu SS, French SW, de Chadarevian JP.
    Pediatr Dev Pathol; 2001 Jan 01; 4(4):344-50. PubMed ID: 11441335
    [Abstract] [Full Text] [Related]

  • 37. Copper and copper-binding protein in fibrolamellar liver cell carcinoma.
    Lefkowitch JH, Muschel R, Price JB, Marboe C, Braunhut S.
    Cancer; 1983 Jan 01; 51(1):97-100. PubMed ID: 6185196
    [Abstract] [Full Text] [Related]

  • 38. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.
    Rudnick DA, Liao Y, An JK, Muglia LJ, Perlmutter DH, Teckman JH.
    Hepatology; 2004 Apr 01; 39(4):1048-55. PubMed ID: 15057909
    [Abstract] [Full Text] [Related]

  • 39. Alpha-1-antitrypsin deficiency and liver diseases in Nigeria.
    Olusi SO.
    Trop Geogr Med; 1990 Jan 01; 42(1):41-6. PubMed ID: 2175465
    [Abstract] [Full Text] [Related]

  • 40. Alpha-1-antitrypsin bodies in the liver.
    Blenkinsopp WK, Haffenden GP.
    J Clin Pathol; 1977 Feb 01; 30(2):132-7. PubMed ID: 191472
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.